The MAD can quickly and effectively deliver the exact dosing and exact volume of atomized nasal medications to both children and adults without needing IV set-up time or a sterile technique. Since there’s no shot and no needle, the MAD avoids the risk of needlestick injury and helps keep patients and caregivers safe.
The MAD is designed to atomize in any position, and the atomized particles it delivers are the optimal size for deposition across a broad area of mucosa. The atomized nasal medications rapidly absorb across olfactory mucosal membranes to the bloodstream into the brain and cerebrospinal fluid. This absorption method thus avoids first-pass metabolism.
With its controlled administration and simple delivery system, the MAD Intranasal Mucosal Atomization Device is appropriate for both ALS and BLS.
This product(s) is classified as a Medical Device which is regulated by the FDA. This product may have regulations or restrictions in some states. It is the customer’s responsibility to determine and comply with all applicable federal, state or local laws.
Special discounts may apply for high volume sales.
Contact our Bids & Quotes department for more information.